Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT. (Q46022237)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 May 2009

edit

Language	Label	Description	Also known as
English	Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT.	scientific article published on 7 May 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

title

Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET/CT. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

main subject

visualization

1 reference

based on heuristic

inferred from title

author name string

Wolfgang Luboldt

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

Klaus Zöphel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

Gerd Wunderlich

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

Andrij Abramyuk

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

Hans-Joachim Luboldt

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

Joerg Kotzerke

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

publication date

7 May 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

published in

Molecular Imaging and Biology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

page(s)

78-84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

cites work

Treatment options for hormone-refractory prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11307-009-0230-3

retrieved

21 January 2018

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11307-009-0230-3

retrieved

21 January 2018

Growth hormone inhibitors in prostate cancer: a systematic analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do neuroendocrine cells in human prostate cancer express androgen receptor?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogues and estrogens in the treatment of androgen ablation refractory prostate adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of neuroendocrine carcinoma by peptide receptor radionuclide therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine tumors. Peptide receptor radionuclide therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine cells in tumour growth of the prostate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EAU guidelines on prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Processing of generator-produced 68Ga for medical application.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of prognostic biomarkers for prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular biology of somatostatin receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19421819

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11307-009-0230-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

PubMed publication ID

19421819

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19421819

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/19421819

ResearchGate publication ID

24407852

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46022237&oldid=2207537024"